From the Congressional Office of Technology Assessment.
Liskowsky
D R
DR
OTA Biological Applications Program, US Congress, Washington, DC 20510.
D037881:Aborted Fetus; D026683:Advisory Committees; D032761:Animal Experimentation; D016380:Brain Tissue Transplantation; D035082:Federal Government; D016332:Fetal Tissue Transplantation; D033161:Government Regulation; D006801:Humans; D010300:Parkinson Disease / Q000601:surgery; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration; D014491:United States Office of Technology Assessment